Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H9I3O3 |
| Molecular Weight | 557.8901 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(OC1=C(I)C=C(I)C=C1I)C(O)=O
InChI
InChIKey=VYAGDYWTCWDKIS-UHFFFAOYSA-N
InChI=1S/C10H9I3O3/c1-2-8(10(14)15)16-9-6(12)3-5(11)4-7(9)13/h3-4,8H,2H2,1H3,(H,14,15)
| Molecular Formula | C10H9I3O3 |
| Molecular Weight | 557.8901 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Recent triiodinated contrast media for oral cholecystocholangiography]. | 1985-02 |
|
| The significance of conjugated phenobutiodil (biliodyl) in the intestine in the absence of gallbladder opacification a preliminary assessment. | 1977-05 |
|
| [Clinical studies with the oral billary contrast medium baygnostil]. | 1959-12-05 |
|
| [Experiences with the triiodated oral gallbladder contrast medium baygnostil]. | 1959-01-30 |
|
| [Baygnostil, a new triiodized oral biliary contrast medium]. | 1958-12 |
|
| [Use of the oral contrast medium baygnostil in cholecystography]. | 1958-11-08 |
|
| [Oral cholecystography with baygnostil]. | 1957-12-13 |
|
| [Baygnostil, a new contrast medium in cholecystography, & its practical trial]. | 1957-11-02 |
|
| A comparative trial of telepaque and biliodyl in 50 cases. | 1957-07 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/862320
Single dose of 3 g (six tablets)
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:29:08 GMT 2025
by
admin
on
Mon Mar 31 19:29:08 GMT 2025
|
| Record UNII |
67F5J7GUUR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
473
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
SUB09772MIG
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104664
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
3812
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
554-24-5
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
m883
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000082238
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
C166909
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
67F5J7GUUR
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
C008831
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
DTXSID80862188
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
11127
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY | |||
|
209-065-1
Created by
admin on Mon Mar 31 19:29:08 GMT 2025 , Edited by admin on Mon Mar 31 19:29:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |